FALZONI, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 10.414
EU - Europa 9.300
AS - Asia 5.567
SA - Sud America 810
Continente sconosciuto - Info sul continente non disponibili 227
AF - Africa 120
OC - Oceania 16
Totale 26.454
Nazione #
US - Stati Uniti d'America 10.163
FI - Finlandia 5.971
SG - Singapore 2.125
CN - Cina 1.370
DE - Germania 1.047
IT - Italia 657
VN - Vietnam 645
BR - Brasile 627
HK - Hong Kong 419
UA - Ucraina 395
GB - Regno Unito 269
TR - Turchia 267
RU - Federazione Russa 233
PL - Polonia 188
FR - Francia 184
BD - Bangladesh 183
JP - Giappone 136
CA - Canada 113
SE - Svezia 113
IN - India 104
MX - Messico 83
ID - Indonesia 82
AR - Argentina 65
NL - Olanda 54
IQ - Iraq 39
ZA - Sudafrica 37
LT - Lituania 35
ES - Italia 27
EC - Ecuador 26
PK - Pakistan 26
CO - Colombia 23
PH - Filippine 23
BE - Belgio 22
UZ - Uzbekistan 21
VE - Venezuela 19
PY - Paraguay 17
SA - Arabia Saudita 17
AT - Austria 16
IE - Irlanda 16
AU - Australia 15
CZ - Repubblica Ceca 12
IL - Israele 12
JM - Giamaica 12
KE - Kenya 12
MA - Marocco 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
TN - Tunisia 11
CL - Cile 10
CR - Costa Rica 10
EG - Egitto 10
IR - Iran 10
DZ - Algeria 9
LV - Lettonia 9
MY - Malesia 8
OM - Oman 8
AZ - Azerbaigian 7
KR - Corea 7
NP - Nepal 7
PA - Panama 7
RO - Romania 7
BO - Bolivia 6
CH - Svizzera 6
DK - Danimarca 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
BB - Barbados 5
ET - Etiopia 5
JO - Giordania 5
MD - Moldavia 5
PS - Palestinian Territory 5
BG - Bulgaria 4
KZ - Kazakistan 4
LB - Libano 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
GR - Grecia 3
KG - Kirghizistan 3
MU - Mauritius 3
NI - Nicaragua 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
BH - Bahrain 2
BJ - Benin 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
NG - Nigeria 2
QA - Qatar 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
Totale 26.209
Città #
Helsinki 5.809
Singapore 1.321
Ashburn 1.234
Fairfield 801
Woodbridge 781
San Jose 774
Santa Clara 499
Houston 495
Chandler 483
Beijing 449
Jacksonville 434
Hong Kong 411
Munich 387
Ann Arbor 354
Seattle 301
Wilmington 273
Ferrara 262
Cambridge 250
Council Bluffs 247
Ho Chi Minh City 202
Dallas 199
Los Angeles 173
Warsaw 171
New York 164
Hanoi 157
Izmir 142
Nanjing 133
Tokyo 125
Princeton 112
Addison 106
Lauterbourg 99
San Diego 85
Boardman 80
Shanghai 78
Buffalo 58
Milan 57
São Paulo 56
Jakarta 54
Turku 54
Mexico City 49
Chicago 46
Orem 44
Atlanta 43
London 42
The Dalles 42
Nanchang 39
Toronto 38
Dong Ket 37
Shenyang 37
Da Nang 36
Moscow 35
Frankfurt am Main 34
Dearborn 33
Bremen 32
Brooklyn 32
Chennai 32
Montreal 31
Hebei 30
Hefei 30
Denver 28
Tianjin 26
Changsha 25
Nuremberg 25
Phoenix 25
San Francisco 24
Jiaxing 23
Johannesburg 23
Boston 22
Hải Dương 22
Manchester 22
Stockholm 22
Columbus 21
Rome 21
Amsterdam 20
Brussels 20
Jinan 20
Tashkent 20
Haiphong 17
Norwalk 17
Baghdad 16
Poplar 16
Bologna 15
Rio de Janeiro 15
Brasília 14
Falkenstein 14
Jyväskylä 14
Ningbo 14
Philadelphia 14
San Mateo 14
Augusta 13
Curitiba 13
Guangzhou 13
Salvador 13
Washington 13
Biên Hòa 12
Dhaka 12
Dublin 12
Mountain View 12
Redwood City 12
Falls Church 11
Totale 19.337
Nome #
A new luciferase target to the extracellular surface of the plasma membrane reveals a new pathway for ATP release in live intact cells. 2.241
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 2.164
A new method for measuring local ATP release at the extracellular surface of live intact cells 2.086
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 425
Characterization of P2X7 isoform B sheds light on the role of pore versus channel activity in P2X7 mediated life and death. 377
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 330
P2X7 targeting inhibits growth of human mesothelioma 315
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 297
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 285
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 276
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 269
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells 267
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 266
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 261
ATP-mediated cytotoxicity in microglial cells 258
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 240
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 238
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 235
ATP receptors and giant cell formation 234
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 233
The P2X7 Receptor in Infection and Inflammation 228
Blockade of P2X7 receptor inhibits formation of multinucleated giant cells. 226
The antibiotic polymyxin B modulates P2X7 receptor function 224
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 222
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 222
Purinoceptor function in the immune system 217
Dysfunctional inflammasome in Schnitzler's syndrome 217
The P2X7 receptor is a key modulator of aerobic glycolysis. 216
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 212
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 210
Altered IL-1ß secretion in a patient affected by Schnitzler's syndrome 207
P2 receptors in cancer progression and metastatic spreading 206
Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells 206
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 204
ATP in the tumour microenvironment drives expression of nfP2X(7), a key mediator of cancer cell survival 204
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance 203
In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe 201
CYTOLYTIC P2X PURINOCEPTORS 198
The P2X7 receptor-interleukin-1 liaison 195
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 193
Altered IL-1 beta secretion in a patient affected by Schintzler's syndrome 193
Trophic activity of a naturally occuring isoform of the P2X7 receptor 191
Stable expression in HEK293 cells and characterization of P2X7 isoform B: new hints on P2X7 mediated cell survival. 190
Expression of the P2X7 receptor and metabolic adaptation in serum and glucose deprivation 190
Cellular biosensors for the identification of fetal hemoglobin inducers 189
The P2 purinergic receptors of human dendritic cells: Identification and coupling to cytokine release 186
The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility 185
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 184
Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation 183
High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts 182
P2X7 receptor has a key role in multinucleated giant cells formation. 179
The P2X7-inflammasome connection: a novel pathway in autoinflammatory diseases. 178
Association of Hypomorphic P2X7 Receptor Genotype With Age 178
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 174
Activation of microglia by amyloid  requires P2X7 receptor expression 174
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 173
CHIMERIC PROTEINS FOR MEASURING ATP CONCENTRATIONS IN PERICELLULAR SPACE AND RELATED SCREENING METHOD 173
P2 purinoceptors in the immune system 171
Association of 1513CC P2X7 receptor genotype with age 171
Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7 169
Use of luciferase probes to measure ATP in living cells and animals 167
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 165
The P2Z/P2X7 receptor of microglial cells: A novel immunomodulatory receptor 164
P2X7 receptor and polykarion formation 163
The P2X7 receptor for extracellular nucleotides: a novel player in bone remodelling 163
Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth 163
Detecting adenosine triphosphate in the pericellular space 162
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 162
Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes 162
Signalling by extracellular nucleotides in health and disease 162
Expression and function of the P2X7 receptor in human osteoblasts: The role of NFATc1 transcription factor 159
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 157
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 157
The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism 156
P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors 151
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 150
Purinergic signaling in giant cell formation 147
Expression of the P2X7 receptor add metabolic adaptation in serum and glucose deprivation 146
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 145
Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra 143
Immunological evidence of an early seroconversion to oncogenic Merkel cell polyomavirus in healthy children and young adults 142
Effects of extracellular ATPand adenosine on osteoclast development 142
The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia 141
Modulation of Cell Energy Metabolism by the P2X7 Receptor 137
Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions 135
Mitochondrial Localization and Function of Adenosine Receptors 134
Extracellular ATP causes ROCK I-dependent bleb formation in P2X(7)-transfected HEK293 cells 133
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 131
Fetal bovine serum contains biologically available ATP 128
Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin 127
Islet-Derived eATP Fuels Autoreactive CD8+ Cells and Facilitates the Onset of Type 1 Diabetes 127
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine 123
The purinergic P2Z receptor is expressed by human macrophages and upregulated by gamma interferon 122
P2Z purinergic receptor expression correlates with spontaneous cell death of J774 macrophages in vitro 119
SCHNITZLER AND SAPHO SYNDROMES: A MOLECULAR LINK BETWEEN P2X7 RECEPTOR AND INFLAMMASOME COMPLEX 119
Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X(7) receptor 119
Assessing Extracellular ATP as Danger Signal In Vivo: The pmeLuc System 117
Human P2X7 isoform B: a trophic receptor 116
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. 112
Extracellular ATP in cancer 110
Totale 24.799
Categoria #
all - tutte 98.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.150
Totale 102.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.111 0 123 56 37 40 35 80 51 29 84 111 465
2022/20231.090 119 66 35 133 183 141 39 127 146 10 65 26
2023/2024711 76 86 33 15 86 108 37 60 16 8 29 157
2024/20253.273 67 78 205 143 335 409 207 214 584 297 385 349
2025/202613.556 876 290 604 925 1.202 469 1.051 448 6.317 821 325 228
2026/2027508 222 286 0 0 0 0 0 0 0 0 0 0
Totale 26.454